[Genomics-創] Results of the Company's Price Stabilization Operations for the First Five Business Days of Listing on the Innovation Board
NQ Score
0/100
N1 Content Completeness
8
AI Summary (NQ-processed)
Genomics BioSci & Tech Co., Ltd. announced the completion of its price stabilization operation for the first five days of its IPO, with the underwriter purchasing 130,000 shares at NT$22.06 per share.